1. Erythrocyte 2,3-diphosphoglycerate (2,3-DPG) and adenosine triphosphate (ATP) were determined in normal individuals, uraemic patients on chronic haemodialysis and patients who underwent renal transplantation, and correlated with plasma phosphate and arterial blood pH.
Introduction
Almost all patients with chronic renal failure are anaemic. Although their erythrocyte mass usually increases on chronic haemodialysis (Eschbach, Funk, Adamson, Juhn, Scribner & Finch, 1967) , total correction only occurs after successful renal transplantation (Farooki & Kimber, 1971) . Erythrocytes in uraemia display an increased rate of glycolysis and their amounts of 2,3-DPG and ATP have been found to be elevated (Lichtman & Miller, 1970; Blumberg & Marti, 1972) . It has been postulated that the stimulus for glycolysis is the elevated serum phosphate, characteristic of patients with chronic renal failure (Lichtman & Miller, 1970) .
Acute hypophosphataemia markedly reduces erythrocyte glycolysis in a variety of clinical states, with concomitant reductions in erythrocyte 2,3-DPG and ATP (Lichtman, Miller, Cohen & Waterhouse, 1971 ; Travis, Sugarman, Ruberg, Dudrick, Delivoria-Papadopoulos, Miller & Oski, 1971; Yawata, Hebbel, Silvis, Howe & Jacob, 1974) . These alterations have been assumed to play a significant role in the development of erythrocyte destruction, leucocyte dysfunction and platelet abnormalities (Yawata, et al., 1974) . After successful renal allotransplantation from living donors, elaboration of large urine volumes is commonly associated with pronounced reductions of serum phosphate concentration. This is usually the result of marked phosphaturia (Alfrey, Jenkins, Groth, Schorr, Gecelter & Ogden, 1968) .
In view of the importance of an adequate oxygen delivery by erythrocytes and appro-priate leucocyte function in patients receiving immunosuppressive agents, we studied the effects of the acute hypophosphataemia that develops after renal transplantation on the concentrations of erythrocyte 2,3-DPG and ATP. Such studies, conducted immediately after transplantation, also allowed a reassessment of the role of hyperphosphataemia in the elevated organic phosphates of erythrocytes.
Methods
After informed consent from all subjects was obtained, blood samples were drawn from patients with end-stage renal failure maintained on thrice-weekly haemodialysis. Each patient had been treated on a coil dialyser for longer than 6 months. Studies were also conducted on patients who had received a kidney transplant at least 4 months previously and whose packed cell volumes were stable on at least three separate determinations. Their results were compared with similar measurements on non-smoking, healthy volunteer subjects who had no evidence of renal, haematological or pulmonary disease. Eight patients were studied in the days immediately before and after they received a renal transplant from a related living donor (Table 1) .
They were receiving prednisolone (2 mg/kg body weight) and azathioprine (2.5 mg/kg body weight) during the days before the pre-transplant samples were obtained and through the period of observation. Five of the patients had received a blood transfusion 4 days before the renal transplant was performed and 2,3-DPG and ATP had returned to pre-transfusion values by the day of surgery. Two additional subjects with end-stage renal failure on haemodialysis were studied as outpatients. Both received a low-phosphate diet supplemented with phosphate binders (magnesium-aluminum hydroxide), to reduce the concentration of the serum phosphate to values comparable with those observed in the transplanted patients. Haemodialysis was performed for 6 h. When diluted, concentrations in the dialysis fluid were Na 130 mmol/l, C1 104 mmol/l, K 2.5 mmol/l, acetate 37 mmol/l, Mg 1.5 mmol/l, Ca 2.5 mmol/l and glucose 11 mmol/l. Blood flow during dialysis was maintained at 200 ml/min. Dialysis fluid flow averaged 300 mllmin. Blood samples were procured before haemodialysis in the uraemic patients, or in a fasting state after surgery either by puncture of the arterial end of a radial arteriovenous fistula or from the arterial side of an indwelling brachial arteriovenous cannula. All samples were drawn anaerobically in a disposable heparinized syringe and processed immediately.
Whole blood pH, Pco2 and Po2 were measured at 37°C in a pH/blood gas analyser (American Instruments, model 3 13). Packed cell volume was determined as the mean value of three measurements in a micro-haematocrit centrifuge. Haemoglobin was determined in a Coulter Counter. Serum phosphate was measured on a Technicon Auto-Analyzer by the method of Ye (1968). 2,3-DPG was measured spectrophotometrically on haemolysed whole blood collected in a 1 :100 dilution with ice-cold water by an enzymatic method in which the change in absorbance related to the degradation of 3-phosphoenolpyruvate in the presence of phosphoglycerate mutase, enolase and magnesium chloride was measured over 4 min at 30°C, and the concentration of 2,3-DPG read from a plotted standard graph (Calbiochem, 2,3-DPG Statpack). ATP was assayed spectrophotometrically in a neutralized perchloric acid (2 mol/l) extract of whole blood, by means of yeast hexokinase and glucose 6-phosphate dehydrogenase (Lamprecht & Trautschold, 1971) . Results were expressed in mmol/l of erythrocytes. The extracts were stored frozen at -20°C until assayed, usually within a week. All samples were analysed in duplicate and all determinations in a single patient were processed at the same time. Statistical analysis was by Student's t-test.
Results are shown as mean values f SD.
Results
Erythrocyte contents of ATP and 2,3-DPG and the serum phosphate concentration of the uraemic patients were significantly higher than those of the control group (P<O.OOl). Their packed cell volumes and haemoglobin were substantially lower (Table 2 ). Comparative studies after renal transplantation showed that, on the fifth day, the serum phosphate had fallen to 0-14 f 0.04 mmol/l but the 2,3-DPG and ATP remained elevated : 4.98 f 0.8 and 1-91 + 0.3 mmol/l of erythrocytes respectively. In the patients studied several months later, when the packed cell volume and haemoglobin values had become normal, the 2,3-DPG and ATP content of the erythrocytes returned to normal (3.91 f 0.59 and 1.24 f0.28 mmol/l of erythrocytes).
In the eight patients studied prospectively (Fig. l) Reticulocyte counts were done at different intervals in some of the patients. The results were variable, although reticulocytosis was observed in three patients (mean 2.6; range 0.1-11.0 reticulocytes %). In three other subjects, the number of cefls stayed between 0.1 and 4.2% (mean 1.4) during the 10 days of daily determinations.
Arterial blood pH showed marked interpatient variations in daily determinations, making statistical analysis very difficult (Table  3) tended to remain in an alkaline range, with a low Pcoz, and a serum bicarbonate in the low normal range. There was a very significant correlation between arterial blood pH and erythrocyte 2,3-DPG (r = 0.52; P < 0.001), but no such correlation could be established for blood pH with erythrocyte ATP (Fig. 2) . Comparison of plasma phosphate with 2,3-DPG and ATP ( Fig. 3 and Fig. 4) did not show any correlation in spite of the wide variation of phosphate values (0,0648 mmol/l). In the two uraemic patients on chronic haemodialysis, in whom plasma phosphate concentration was reduced by the administration of antacids, erythrocyte ATP and 2,3-DPG decreased markedly when phosphate values were lowered to normal (Fig. 5) . Values as low as 0.29 mmol of ATP/I of erythrocytes persisted in one (Lichtman & Miller, 1970) ; this elevation presumably increases the concentrations of 2,3-DPG and ATP. The increased erythrocyte 2,3-DPG and ATP in uraemia has been attributed to hyperphosphataemia. Decreases in the serum phosphate in uraemic patients have been correlated with marked falls in amounts of these metabolites within a few days of onset of hypophosphataemia. A slow return to the pre-existing values is observed after the phosphate increases again (Lichtman, Miller & Freeman, 1969 ). In contrast, this temporal relationship was not observed in our transplanted patients.
Our observations indicate that in the immediate post-renal transplant period, the maintenance of high erythrocyte ATP and 2,3-DPG concentrations is not dependent on the presence of hyperphosphataemia and that, in spite of a very low plasma phosphate concentration, the concentrations remain elevated. Hypophosphataemia may diminish the glycolytic rate of erythrocytes by decreasing the activity of glyceraldehyde 3-phosphate dehydrogenasc (Travis et al., 1971 ). The phosphate concentrations at which this occurs are usually very low, but significant correlations have been established at all levels of serum phosphate. In the post-transplant patients, the majority of the determinations are within 0 , 1 4 2 mmol/l, with several values below 0.1 mmol/l. A correlation could not be established between ATP and 2,3-DPG values and plasma phosphate. In sharp contrast, therapeutic depression of plasma phosphate in two uraemic individuals caused dramatic depression of erythrocyte 2,3-DPG and ATP. These findings indicate that erythrocytes of successfully transplanted patients maintain high concentrations of 2,3-DPG and ATP despite hypophosphataemia, which in other circumstances could lead to their decline.
Besides serum phosphate concentration, other factors influence erythrocyte 2,3-DPG and ATP. These include pH, anoxia and certain drugs including androgens and thyroid hormones (Parker, Beirne, Desai, Raich & Shahidi, 1972) . Thus acidosis decreases glycolysis and alkalosis stimulates it. A significant correlation between pH and erythrocyte 2,3-DPG has been reported with various acid-base disorders (Astrup, 1970) , as well as in normal subjects during altitudeinduced hypoxia and exogenously induced metabolic derangements (Billingham, Detter & Lenfant, 1971) . In uraemic patients raised amounts of 2,3-DPG are found in spite of metabolic acidosis. It has been postulated, however, that because of the acidosis present they are inappropriately low for the degree of anaemia, and correction of the acidosis in four uraemic patients has resulted in increase of the 2,3-DPG content of the erythrocytes to values compatible with the haemoglobin deficit (Lichtman, Murphy, Whitbeck & Kearney, 1974) . The exact inter-relations between blood pH, serum phosphate, erythrocyte 2,3-DPG and ATP in uraeniia are not completely clear. Studies performed during haemodialysis have shown conflicting results: uniform falls in serum phosphate and increases in blood pH are reported; in some studies the erythrocyte ATP or the 2,3-DPG are found to fall concomitantly with serum phosphate (Raich, Rodriguez, Desai & Shahidi, 1973; Chillar & Desforges, 1974; Hirzel, Maher, Temple & Mengel, 1975) , whereas other investigators have found no correlation with decrease in serum phosphate or increase in arterial blood pH (Miller, Zaroulis, Valeri & Stohlman, 1974; Lichtman, Murphy, Byer & Freeman, 1974) . In our studies, in the immediate post-transplant period arterial blood pH was observed to rise, probably from rapid elimination of accumulated acid metabolites, restoration of the kidney's capability to regenerate bicarbonate and an unexplained respiratory alkalosis. Although this change toward an alkaline pH was significantly correlated with changes in 2,3-DPG concentration, the same correlation could not be established for ATP. Although no actual measurements were done, an increase in pH would increase the enzymatic activity and the amounts of the compounds by accelerating the glycolytic rate and would tend to confirm the observations that blood pH is a more important regulator of erythrocyte glycolysis than the serum inorganic phosphate. Our studies in the post-transplant patient contrast with the observations of Ditzel (1973) of persistent decrease in erythrocyte 2,3-DPG in patients that have persistent hypophosphataemia after correction of diabetic ketoacidosis, and those of Young, Lichtman & Cohen (1973) which demonstrated a significant correlation between circulating serum phosphate concentrations and erythrocyte ATP and 2,3-DPG in patients studied immediately after cardiovascular surgery.
Young erythrocytes metabolize glucose at a more rapid rate than old erythrocytes. Their larger content of ATP and 2,3-DPG could explain some of the persistent elevations observed. However, this was not a consistent finding in all the patients, and no correlation could be established between reticulocyte counts and ATP or 2,3-DPG. Moreover, the reticulocytosis was not observed until several days after the transplantation, whereas ATP and 2,3-DPG values had already been high.
The findings by some investigators of reduced glycolysis in erythrocytes of uraemia is very likely attributable to acidosis (Morgan & Morgan, 1964) . The addition of uraemia serum to erythrocytes and muscle cells depresses glucose consumption (Dzurik & Valovicova, 1970) . The findings by Lichtmann & Miller (1970) that the hyperphosphataemia of uraemia is a major factor in elevation of erythrocyte ATP, help to explain some of these contradictions. If a uraemic toxin should depress glycolysis, the hyperphosphataemia would tend to over-ride the effect and stimulate glucose consumption. The lowering of the serum phosphate to normal values in the presence of uraemia and acidosis would decrease the concentrations of ATP and 2,3-DPG, as observed in our two uraemic patients. Our observations in posttransplant patients seem to indicate a less important role for phosphate. After renal transplantation, rapid removal of toxic metabolites, systemic alkalosis, and the presence of severe anaemia, would overcome the sudden hypophosphataemia that ensues after the regaining of renal function.
The persistent elevation of ATP and 2,3-DPG in spite of hypophosphataemia should maintain a shift in the oxyhaemoglobin dissociation curve to the right in the presence of low amounts of haemoglobin with its beneficial effects in tissue oxygen delivery. In the days immediately after renal transplantation, this would be a clear advantage for delivery of oxygen in these anaemic individuals.
